Skip to main content
. 2015 Apr 22;79(5):820–830. doi: 10.1111/bcp.12556

Table 3.

Parameter estimates of the pharmacokinetic–pharmacodynamic models

Parameter Analysis of COWA as continuous data Poisson distribution for discrete data
Estimate RSE (%) Estimate RSE (%)
BL (words per three trials) 42.5 3.48 42.4 3.51
KE (l mg−1) 0.157 6.97 0.163 16.7
θN_COWA ≥ 4 1.12 2.38 1.13 2.35
%CV for IIV of BL 17 [9] 26.2 17.6 [6] 25.7
Inline graphic (words per three trials) 7.1 [8] 15.4
AIC 829 1124

Abbreviations are as follows: AIC, Akaike information criterion; BL, baseline score of COWA; COWA, Controlled Oral Word Association; KE, the exponential decline constant for the effect of topiramate concentration; θN_COWA ≥ 4, estimate of the fractional increase in BL when four or more tests of COWA are given; estimates of percentage shrinkage are indicated in the square brackets [% shrinkage]; Inline graphic, variance of the residual error. †RSE, relative standard error = (standard error ÷ estimate) × 100; %RSE for random effects calculated in the variance scale. ‡IIV, interindividual variability; CV, coefficient of variation; Inline graphic.

HHS Vulnerability Disclosure